vs

Side-by-side financial comparison of MANNKIND CORP (MNKD) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

MANNKIND CORP is the larger business by last-quarter revenue ($112.0M vs $71.1M, roughly 1.6× RE/MAX Holdings, Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -14.2%, a 16.3% gap on every dollar of revenue. On growth, MANNKIND CORP posted the faster year-over-year revenue change (45.8% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-10.0M). Over the past eight quarters, MANNKIND CORP's revenue compounded faster (30.0% CAGR vs -4.7%).

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

MNKD vs RMAX — Head-to-Head

Bigger by revenue
MNKD
MNKD
1.6× larger
MNKD
$112.0M
$71.1M
RMAX
Growing faster (revenue YoY)
MNKD
MNKD
+47.7% gap
MNKD
45.8%
-1.8%
RMAX
Higher net margin
RMAX
RMAX
16.3% more per $
RMAX
2.0%
-14.2%
MNKD
More free cash flow
RMAX
RMAX
$43.5M more FCF
RMAX
$33.5M
$-10.0M
MNKD
Faster 2-yr revenue CAGR
MNKD
MNKD
Annualised
MNKD
30.0%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MNKD
MNKD
RMAX
RMAX
Revenue
$112.0M
$71.1M
Net Profit
$-15.9M
$1.4M
Gross Margin
87.6%
Operating Margin
-6.9%
13.1%
Net Margin
-14.2%
2.0%
Revenue YoY
45.8%
-1.8%
Net Profit YoY
-314.9%
-75.2%
EPS (diluted)
$-0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MNKD
MNKD
RMAX
RMAX
Q4 25
$112.0M
$71.1M
Q3 25
$82.1M
$73.2M
Q2 25
$76.5M
$72.8M
Q1 25
$78.4M
$74.5M
Q4 24
$76.8M
$72.5M
Q3 24
$70.1M
$78.5M
Q2 24
$72.4M
$78.5M
Q1 24
$66.3M
$78.3M
Net Profit
MNKD
MNKD
RMAX
RMAX
Q4 25
$-15.9M
$1.4M
Q3 25
$8.0M
$4.0M
Q2 25
$668.0K
$4.7M
Q1 25
$13.2M
$-2.0M
Q4 24
$7.4M
$5.8M
Q3 24
$11.6M
$966.0K
Q2 24
$-2.0M
$3.7M
Q1 24
$10.6M
$-3.4M
Gross Margin
MNKD
MNKD
RMAX
RMAX
Q4 25
87.6%
Q3 25
94.5%
Q2 25
94.0%
Q1 25
95.2%
Q4 24
93.7%
Q3 24
95.4%
Q2 24
92.3%
Q1 24
94.2%
Operating Margin
MNKD
MNKD
RMAX
RMAX
Q4 25
-6.9%
13.1%
Q3 25
23.0%
25.0%
Q2 25
6.9%
19.3%
Q1 25
28.5%
7.2%
Q4 24
34.5%
5.9%
Q3 24
18.2%
19.4%
Q2 24
22.9%
20.6%
Q1 24
25.2%
5.8%
Net Margin
MNKD
MNKD
RMAX
RMAX
Q4 25
-14.2%
2.0%
Q3 25
9.7%
5.4%
Q2 25
0.9%
6.4%
Q1 25
16.8%
-2.6%
Q4 24
9.7%
8.0%
Q3 24
16.5%
1.2%
Q2 24
-2.8%
4.7%
Q1 24
16.0%
-4.3%
EPS (diluted)
MNKD
MNKD
RMAX
RMAX
Q4 25
$-0.05
Q3 25
$0.03
Q2 25
$0.00
Q1 25
$0.04
Q4 24
$0.03
Q3 24
$0.04
Q2 24
$-0.01
Q1 24
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MNKD
MNKD
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$171.3M
$118.7M
Total DebtLower is stronger
$354.6M
$432.2M
Stockholders' EquityBook value
$-51.0M
$452.4M
Total Assets
$792.2M
$582.5M
Debt / EquityLower = less leverage
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MNKD
MNKD
RMAX
RMAX
Q4 25
$171.3M
$118.7M
Q3 25
$260.0M
$107.5M
Q2 25
$179.0M
$94.3M
Q1 25
$181.5M
$89.1M
Q4 24
$197.3M
$96.6M
Q3 24
$251.6M
$83.8M
Q2 24
$247.8M
$66.1M
Q1 24
$300.7M
$82.1M
Total Debt
MNKD
MNKD
RMAX
RMAX
Q4 25
$354.6M
$432.2M
Q3 25
$109.7M
$433.3M
Q2 25
$36.2M
$434.4M
Q1 25
$36.1M
$435.3M
Q4 24
$36.1M
$436.2M
Q3 24
$227.9M
$437.2M
Q2 24
$227.6M
$438.1M
Q1 24
$264.1M
$439.0M
Stockholders' Equity
MNKD
MNKD
RMAX
RMAX
Q4 25
$-51.0M
$452.4M
Q3 25
$-44.6M
$448.1M
Q2 25
$-55.0M
$442.4M
Q1 25
$-58.6M
$433.5M
Q4 24
$-78.8M
$429.5M
Q3 24
$-209.9M
$423.1M
Q2 24
$-225.8M
$418.4M
Q1 24
$-230.0M
$412.0M
Total Assets
MNKD
MNKD
RMAX
RMAX
Q4 25
$792.2M
$582.5M
Q3 25
$494.6M
$582.2M
Q2 25
$411.7M
$574.8M
Q1 25
$410.1M
$571.4M
Q4 24
$393.8M
$581.6M
Q3 24
$464.2M
$578.6M
Q2 24
$443.8M
$571.4M
Q1 24
$480.9M
$566.7M
Debt / Equity
MNKD
MNKD
RMAX
RMAX
Q4 25
0.96×
Q3 25
0.97×
Q2 25
0.98×
Q1 25
1.00×
Q4 24
1.02×
Q3 24
1.03×
Q2 24
1.05×
Q1 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MNKD
MNKD
RMAX
RMAX
Operating Cash FlowLast quarter
$-8.0M
$40.9M
Free Cash FlowOCF − Capex
$-10.0M
$33.5M
FCF MarginFCF / Revenue
-8.9%
47.1%
Capex IntensityCapex / Revenue
1.8%
10.4%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$13.7M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MNKD
MNKD
RMAX
RMAX
Q4 25
$-8.0M
$40.9M
Q3 25
$23.6M
$17.7M
Q2 25
$8.9M
$4.6M
Q1 25
$-6.4M
$5.7M
Q4 24
$22.6M
$59.7M
Q3 24
$9.3M
$17.6M
Q2 24
$3.8M
$15.9M
Q1 24
$6.7M
$9.4M
Free Cash Flow
MNKD
MNKD
RMAX
RMAX
Q4 25
$-10.0M
$33.5M
Q3 25
$22.5M
$16.4M
Q2 25
$7.8M
$2.9M
Q1 25
$-6.7M
$4.0M
Q4 24
$19.7M
$53.0M
Q3 24
$7.9M
$16.3M
Q2 24
$861.0K
$14.0M
Q1 24
$4.3M
$6.8M
FCF Margin
MNKD
MNKD
RMAX
RMAX
Q4 25
-8.9%
47.1%
Q3 25
27.4%
22.4%
Q2 25
10.2%
4.0%
Q1 25
-8.6%
5.3%
Q4 24
25.7%
73.2%
Q3 24
11.3%
20.8%
Q2 24
1.2%
17.8%
Q1 24
6.5%
8.6%
Capex Intensity
MNKD
MNKD
RMAX
RMAX
Q4 25
1.8%
10.4%
Q3 25
1.4%
1.8%
Q2 25
1.5%
2.2%
Q1 25
0.4%
2.3%
Q4 24
3.8%
9.1%
Q3 24
2.0%
1.7%
Q2 24
4.1%
2.4%
Q1 24
3.6%
3.3%
Cash Conversion
MNKD
MNKD
RMAX
RMAX
Q4 25
28.39×
Q3 25
2.96×
4.45×
Q2 25
13.40×
0.97×
Q1 25
-0.48×
Q4 24
3.05×
10.28×
Q3 24
0.81×
18.22×
Q2 24
4.29×
Q1 24
0.63×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MNKD
MNKD

Products$50.4M45%
Royalty$33.6M30%
Afrezza$22.9M20%
V Go$4.3M4%

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons